Aadi Bioscience Revenue, Growth & Competitor Profile

DBA AADI

Company Profile & Annual Report for Aadi Bioscience

Access the complete profile.

Aadi Bioscience Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325412 Pharmaceutical Preparation Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	17383 Sunset Blvd Ste A250 Pacific Palisades, CA 90272

Note: Revenues for privately held companies are statistical evaluations.


Aadi Bioscience's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Aadi Bioscience's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Aadi Bioscience is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.

Aadi Bioscience Annual Revenue and Growth Rate

Aadi Bioscience	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Aadi Bioscience's revenues are gauged from an analysis of company filings.

Aadi Bioscience's Income Statement (based on Industry Averages)

Aadi Bioscience P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Aadi Bioscience has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
October 11, 2022	13	100%	$73 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Aadi Bioscience is developing and marketing. Aadi Bioscience doesn't have any recent trademark applications, indicating Aadi Bioscience is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ABVOCUS Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular disease, epilepsy and mitochondrial disease; vaccine preparations; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in the treatment of diseases and disorders in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in pediatric, geriatric, emergency, family, and human preventative medicine for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease; pharmaceutical preparations for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease	07/25/2022
LIFRENZAL Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular disease, epilepsy and mitochondrial disease; vaccine preparations; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in the treatment of diseases and disorders in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in pediatric, geriatric, emergency, family, and human preventative medicine for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease; pharmaceutical preparations for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease	07/25/2022

See all trademarks and details in the Full Report.

Market Share of Aadi Bioscience's Largest Competitors

A competitive analysis shows these companies are in the same general field as Aadi Bioscience, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MERIDIAN MEDICAL TECHNOLOGIES	Columbia, MD	100
SYNTRON BIORESEARCH	Carlsbad, CA	55
RLS USA	Lake Zurich, IL	49
ALORA PHARMACEUTICALS	Alpharetta, GA	42
LANTHEUS HOLDINGS	North Billerica, MA	33
BROADVIEW INVESTMENTS	Royston, GA	32
RESULTS RNA	Orem, UT	29
CIVICA	Lehi, UT	28
HARMONY BIOSCIENCES	Plymouth Meeting, PA	24

Nearby Competitors

These companies are similar in business line and location to Aadi Bioscience. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NATALS	Culver City, CA	100
OCULAR SCIENCE	El Segundo, CA	86
LACLEDE	Rancho Dominguez, CA	49
AADI BIOSCIENCE	Pacific Palisades, CA	13
C H LABORATORIES	Gardena, CA	9
QUANTIMETRIX	Redondo Beach, CA	6

Future Competition: Aadi Bioscience's Fastest Growing Competitors

These companies are in the same general field as Aadi Bioscience and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)